Virtu Financial LLC Vaxxinity, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$1.43 - $4.24 $7,977 - $23,654	-5,579 Reduced 31.27%	12,263 $28,000
Q4 2022 Feb 15, 2023	BUY	$1.31 - $2.62 $23,373 - $46,746	17,842 New	17,842 $25,000
Q2 2022 Aug 09, 2022	BUY	$1.55 - $6.95 $19,778 - $88,682	12,760 New	12,760 $20,000
Q1 2022 May 17, 2022	SELL	$3.7 - $8.6 $61,294 - $142,467	-16,566 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$5.55 - $18.46 $91,941 - $305,808	16,566 New	16,566 $93,000

287K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.